IL17C and neoplasm: Furthermore, the levels of secreted human VEGF were increased by IL-17C injection in tumor tissues (Figure 4), indicating that IL-17C can also promote tumor progression in in vivo mouse xenograft models through IL-17C-stimulated human VEGF production in DLD-1 cells.